MicroRNAs and Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) have recently emerged as a new class of modulators of gene expression. miRNAs control protein synthesis by targeting mRNAs for translational repression or degradation at the posttranscriptional level. These noncoding RNAs are endogenous, single-stranded molecules approximately 22 nucleotides in length and have roles in multiple facets of immunity, from regulation of development of key cellular players to activation and function in immune responses. Recent studies have shown that dysregulation of miRNAs involved in immune responses leads to autoimmunity. Multiple sclerosis (MS) serves as an example of a chronic and organ-specific autoimmune disease in which miRNAs modulate immune responses in the peripheral immune compartment and the neuroinflammatory process in the brain. For MS, miRNAs have the potential to serve as modifying drugs. In this review, we summarize current knowledge of miRNA biogenesis and mode of action and the diverse roles of miRNAs in modulating the immune and inflammatory responses. We also review the role of miRNAs in autoimmunity, focusing on emerging data regarding miRNA expression patterns in MS. Finally, we discuss the potential of miRNAs as a disease marker and a novel therapeutic target in MS. Better understanding of the role of miRNAs in MS will improve our knowledge of the pathogenesis of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886 · cited 12×
“In patients with MS, intensive efforts are directed at identifying biomarkers in body fluids related to underlying disease mechanisms, disease activity and progression, and therapeutic response [288].”
BackgroundInfluentialMicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257 · cited 4×
“Moreover, miR181a was identified as a positive regulator of B lymphocyte differentiation based on evidence that expression of miR181a in hematopoietic stem and progenitor cells resulted in an increase in CD19+ B cells and a decrease in CD8+ T cells [91].”
BackgroundInfluentialRegulation of mRNA Translation and Stability by microRNAs
Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-103103 · Cited by 3,214 · cited 1×
“Also, miRNAs, instead of causing translational repression or mRNA degradation, may relieve translational repression and promote transcription [300, 301].”
BackgroundAn Extensive Class of Small RNAs in Caenorhabditis elegans
Lee, R. C., & Ambros, V. (2001) · Science · doi:10.1126/science.1065329 · Cited by 2,922
Processing of primary microRNAs by the Microprocessor complex
Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F., & Hannon, G. J. (2004) · Nature · doi:10.1038/nature03049 · Cited by 2,784
Bushati, N., & Cohen, S. M. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123406 · Cited by 2,750
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866 · cited 3×
“miR-155 is upregulated in murine macrophages by the synthetic triacylated lipopeptide Pam3CSK4, the synthetic double stranded RNA analog poly(I:C), LPS, and CpG oligonucleotides, suggesting that several TLR ligands can induce miR-155 expression and that miR-155 is involved in the regulation of both bacterial and viral…”
BackgroundMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858 · cited 1×
“Activated microglia and peripherally derived macrophages are shifted towards a strongly proinflammatory phenotype and produce apoptosis-inducing molecules such as the TRAIL and the proinflammatory cytokines TNF-α and IL-1β as well as potentially neurotoxic substances including nitric oxide, oxygen radicals and proteol…”
BackgroundKetting, R. F., Fischer, S. E. J., Bernstein, E., Sijen, T., Hannon, G. J., & Plasterk, R. H. A. (2001) · Genes & Development · doi:10.1101/gad.927801 · Cited by 1,852
Cited by
The role of miRNA in inflammation and autoimmunity
Singh, R. P., Massachi, I., Manickavel, S., Singh, S., Rao, N. P., Hasan, S., Mc Curdy, D. K., Sharma, S., Wong, D., Hahn, B. H., et al. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.07.003 · Cited by 334
Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
Gandhi, R., Healy, B., Gholipour, T., Egorova, S., Musallam, A., Hussain, M. S., Nejad, P., Patel, B., Hei, H., Khoury, S., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23880 · Cited by 258
MiR-155: An Important Regulator of Neuroinflammation
Zingale, V. D., Gugliandolo, A., & Mazzon, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010090 · Cited by 163
NeurimmiRs: microRNAs in the neuroimmune interface
Soreq, H., & Wolf, Y. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.06.009 · Cited by 162
Genetic Association and Altered Gene Expression of Mir-155 in Multiple Sclerosis Patients
Paraboschi, E. M., Soldà, G., Gemmati, D., Orioli, E., Zeri, G., Benedetti, M. D., Salviati, A., Barizzone, N., Leone, M., Duga, S., et al. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12128695 · Cited by 102
New Perspectives in MicroRNA Regulation of Innate Immunity
Gantier, M. P. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0037 · Cited by 82
Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis
Dolati, S., Marofi, F., Babaloo, Z., Aghebati-Maleki, L., Roshangar, L., Ahmadi, M., Rikhtegar, R., & Yousefi, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.050 · Cited by 58
MiR-146a promotes remyelination in a cuprizone model of demyelinating injury
Zhang, J., Zhang, Z. G., Lu, M., Wang, X., Shang, X., Elias, S. B., & Chopp, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.029 · Cited by 56
Identification and functional analysis of specific MS risk miRNAs and their target genes
Luo, D., Wang, J., Zhang, X., Rang, X., Xu, C., & Fu, J. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102044 · Cited by 12
Metadata
- Authors
- Tufekci, K. U., Oner, M. G., Genc, S., & Genc, K.
- Venue
- Autoimmune Diseases
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-27
- ISSN
- 2090-0422 (ISSN-L)
- 2090-0430
- OpenAlex
- W2093775122
- Cited by
- 82
- References
- 55
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.